Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ADPT
|
Francis Lo
Chief People Officer |
SELL
Open market or private sale
|
Direct | 1,569 Reduced 1.66% |
$18,844
$12.01 p/Share
|
Mar 07
2022 |
|
ADPT
|
Kyle Piskel
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 220 Reduced 0.46% |
$2,642
$12.01 p/Share
|
Mar 07
2022 |
|
ADPT
|
Stacy L Taylor
SVP and General Counsel |
SELL
Open market or private sale
|
Direct | 1,569 Reduced 2.04% |
$18,844
$12.01 p/Share
|
Mar 07
2022 |
|
ADPT
|
Sharon Benzeno
Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct | 2,670 Reduced 2.54% |
$32,067
$12.01 p/Share
|
Mar 07
2022 |
|
ADPT
|
Julie Rubinstein
President and COO |
SELL
Open market or private sale
|
Direct | 4,613 Reduced 2.0% |
$55,402
$12.01 p/Share
|
Mar 07
2022 |
|
MNRL
|
Robert M. Roosa
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 6,250 Reduced 1.61% |
$170,125
$27.22 p/Share
|
Mar 07
2022 |
|
MNRL
|
Robert M. Roosa
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 6,250 Reduced 36.0% |
$175,000
$28.0 p/Share
|
Mar 07
2022 |
|
XPEL
|
Richard K. Crumly
Director |
SELL
Open market or private sale
|
Indirect | 19,000 Reduced 0.82% |
$1,083,570
$57.03 p/Share
|
Mar 07
2022 |
|
ADV
|
Tanya L Domier
Executive Chair |
SELL
Open market or private sale
|
Direct | 55,283 Reduced 10.51% |
$303,504
$5.49 p/Share
|
Mar 07
2022 |
|
ADV
|
Brian Stevens
CFO & COO |
SELL
Open market or private sale
|
Direct | 30,066 Reduced 13.21% |
$160,853
$5.35 p/Share
|
Mar 07
2022 |
|
ADV
|
Jill L Griffin
President & CCO |
SELL
Open market or private sale
|
Direct | 30,067 Reduced 9.15% |
$165,068
$5.49 p/Share
|
Mar 07
2022 |
|
ADV
|
Dean Kaye
CFO - North America |
SELL
Open market or private sale
|
Direct | 7,067 Reduced 10.09% |
$38,798
$5.49 p/Share
|
Mar 07
2022 |
|
ADV
|
James M Kilts |
BUY
Open market or private purchase
|
Direct | 56,209 Added 24.19% |
$314,208
$5.59 p/Share
|
Mar 07
2022 |
|
CTKB
|
Wenbin Jiang
PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.25% |
$263,800
$13.19 p/Share
|
Mar 07
2022 |
|
XENE
|
James R. Empfield
EVP, Drug Discovery |
SELL
Payment of exercise price or tax liability
|
Direct | 9,647 Reduced 18.38% |
$291,629
$30.23 p/Share
|
Mar 07
2022 |
|
XENE
|
James R. Empfield
EVP, Drug Discovery |
BUY
Exercise of conversion of derivative security
|
Direct | 42,500 Added 45.07% |
$322,150
$7.58 p/Share
|
Mar 07
2022 |
|
XENE
|
James R. Empfield
EVP, Drug Discovery |
SELL
Open market or private sale
|
Direct | 32,853 Reduced 76.66% |
$1,004,645
$30.58 p/Share
|
Mar 07
2022 |
|
XENE
|
Simon N. Pimstone |
SELL
Payment of exercise price or tax liability
|
Direct | 1,990 Reduced 0.86% |
$60,158
$30.23 p/Share
|
Mar 07
2022 |
|
XENE
|
Simon N. Pimstone |
BUY
Exercise of conversion of derivative security
|
Direct | 20,576 Added 8.19% |
$75,514
$3.67 p/Share
|
Mar 07
2022 |
|
XENE
|
Simon N. Pimstone |
SELL
Open market or private sale
|
Direct | 31,086 Reduced 13.59% |
$948,434
$30.51 p/Share
|
Mar 07
2022 |
|
EXPI
|
Glenn Darrel Sanford
CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct | 9,000 Added 0.02% |
$630
$0.07 p/Share
|
Mar 07
2022 |
|
EXPI
|
Glenn Darrel Sanford
CEO and Chairman of the Board |
SELL
Open market or private sale
|
Direct | 9,000 Reduced 0.02% |
$216,180
$24.02 p/Share
|
Mar 07
2022 |
|
CBZ
|
Michael P Kouzelos
President, Employee Services |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 3.15% |
$155,500
$15.55 p/Share
|
Mar 07
2022 |
|
CBZ
|
Michael P Kouzelos
President, Employee Services |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 3.25% |
$391,100
$39.11 p/Share
|
Mar 07
2022 |
|
VNOM
|
Bx Guidon Topco LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 22,593 Reduced 0.09% |
$686,601
$30.39 p/Share
|
Mar 07
2022 |
|
CPE
|
Primexx Energy Partners, LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 475,000 Reduced 2.87% |
$28,918,001
$60.88 p/Share
|
Mar 07
2022 |
|
BRP
|
John A. Valentine
Chief Partnership Officer |
BUY
Open market or private purchase
|
Direct | 500 Added 1.29% |
$12,085
$24.17 p/Share
|
Mar 07
2022 |
|
SFM
|
Jack Sinclair
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 64,047 Reduced 17.38% |
$2,093,696
$32.69 p/Share
|
Mar 07
2022 |
|
SFM
|
Brandon F. Lombardi
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 25,732 Reduced 29.03% |
$894,187
$34.75 p/Share
|
Mar 07
2022 |
|
SFM
|
Brandon F. Lombardi
Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 25,732 Added 22.5% |
$883,380
$34.33 p/Share
|
Mar 07
2022 |
|
SFM
|
David Mc Glinchey
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 5,103 Reduced 13.05% |
$166,817
$32.69 p/Share
|
Mar 07
2022 |
|
SFM
|
Dan J Sanders
Chief Store Operations Officer |
SELL
Open market or private sale
|
Direct | 5,412 Reduced 13.2% |
$176,864
$32.68 p/Share
|
Mar 07
2022 |
|
GATX
|
Robert Zmudka
Sr. VP & Chief Comm. Off. |
SELL
Open market or private sale
|
Direct | 578 Reduced 9.06% |
$66,447
$114.96 p/Share
|
Mar 07
2022 |
|
IAA
|
Peter Kamin
Director |
BUY
Open market or private purchase
|
Indirect | 28,000 Added 7.63% |
$935,480
$33.41 p/Share
|
Mar 07
2022 |
|
PRGO
|
Ronald Craig Janish
EVP, Gbl Ops & SC & CTO |
SELL
Open market or private sale
|
Direct | 3,954 Reduced 20.13% |
$145,230
$36.73 p/Share
|
Mar 07
2022 |
|
STAG
|
Benjamin S Butcher |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 21.24% |
$396,600
$39.66 p/Share
|
Mar 07
2022 |
|
SRPT
|
Louise Rodino Klapac
Head of R&D, CSO |
BUY
Grant, award, or other acquisition
|
Direct | 8,000 Added 9.99% |
-
|
Mar 07
2022 |
|
SRPT
|
William Ciambrone
EVP |
BUY
Grant, award, or other acquisition
|
Direct | 8,000 Added 26.58% |
-
|
Mar 07
2022 |
|
SRPT
|
Ryan Edward Brown
EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 8,000 Added 23.6% |
-
|
Mar 07
2022 |
|
SRPT
|
Ryan Edward Brown
EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 153 Reduced 0.85% |
$12,142
$79.36 p/Share
|
Mar 07
2022 |
|
SRPT
|
Ian Michael Estepan
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,000 Added 19.67% |
-
|
Mar 07
2022 |
|
SRPT
|
Ian Michael Estepan
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 398 Reduced 1.59% |
$31,585
$79.36 p/Share
|
Mar 07
2022 |
|
LECO
|
Christopher L Mapes
EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct | 9,533 Reduced 5.36% |
$1,219,366
$127.91 p/Share
|
Mar 07
2022 |
|
TEVA
|
Richard Daniell
Exec. VP, European Commercial |
SELL
Open market or private sale
|
Direct | 22,576 Reduced 34.33% |
$166,385
$7.37 p/Share
|
Mar 07
2022 |
|
TEVA
|
Sven Dethlefs
EVP, North America Commercial |
SELL
Open market or private sale
|
Direct | 6,993 Reduced 4.06% |
$51,538
$7.37 p/Share
|
Mar 07
2022 |
|
TEVA
|
Eric Drape
Executive VP Global Operations |
SELL
Open market or private sale
|
Direct | 11,334 Reduced 12.68% |
$83,532
$7.37 p/Share
|
Mar 07
2022 |
|
TEVA
|
Hafrun Fridriksdottir
Executive VP, Global R&D |
SELL
Open market or private sale
|
Direct | 8,941 Reduced 6.62% |
$65,895
$7.37 p/Share
|
Mar 07
2022 |
|
TEVA
|
David Matthew Stark
Exec. VP Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 9,057 Reduced 12.9% |
$66,750
$7.37 p/Share
|
Mar 07
2022 |
|
HSIC
|
James P Breslawski
President |
SELL
Open market or private sale
|
Direct | 8,923 Reduced 4.21% |
$773,803
$86.72 p/Share
|
Mar 07
2022 |
|
HSIC
|
Mark E Mlotek
EVP, Chief Strategic Officer |
SELL
Open market or private sale
|
Direct | 6,292 Reduced 8.72% |
$543,566
$86.39 p/Share
|
Mar 07
2022 |